- Starting price
- Free 3-day trial, then $14.99/mo
- Free tier
- No
- Platforms
- iOS - Android
- Developer
- SWITCH ON YOUR BRAIN INTERNATIONAL LLC
- Launched
- 2019
- Updated
- Jul 27, 2026
The verdict
Neurocycle is a well-built, disciplined daily journaling program with an unusually strong opinion about why it works, and the science it cites is thinner than the marketing implies: the headline peer-reviewed trial finished with 11 people. Buy it if a structured 63-day written practice appeals and you can hear "up to 81%" as a marketing number rather than a clinical one. Do not buy it as a substitute for care - the vendor's own terms say it does not treat any condition, and anyone with a diagnosed anxiety or depressive illness should be talking to a clinician, not an app.
Try Neurocycle ↗Opens neurocycle.app
Neurocycle is the app version of a method Dr Caroline Leaf has been publishing since her book Switch On Your Brain. The mechanic is a five-step daily cycle - Gather Awareness, Reflect, Write, Recheck, Active Reach - repeated once a day for 63 days in three 21-day phases, at 15 to 45 minutes a sitting. Steps three and five are the ones that carry the product: you write down what you noticed, and you commit to a single "active reach" thought or action to rehearse the next day. Stripped of its framing, it is a highly structured guided journal with an audio teacher.
The framing is not stripped, though, and it is the reason this review is longer than a journaling app usually warrants. The App Store description opens: "Eliminate stress, anxiety, depression and toxic thinking with the first ever scientifically-tested brain detox app!" The vendor's own site claims the method is "Scientifically demonstrated to show up to 81% improvement in managing symptoms of anxiety and depression." The App Store listing is titled Stress Therapy: Neurocycle, subtitled "Get relief from mental anxiety," and Apple has attached a content advisory for "Frequent/Intense Medical/Treatment Information." Every one of those is a claim about treating illness.
The terms and conditions on the vendor's own domain say something different, in capitals: "COMPANY IS A PROVIDER OF POSITIVE THINKING TRAINING IN THE HEALTH & WELLNESS SPACE. WE ARE NOT A HEALTH CARE OR MEDICAL DEVICE PROVIDER," and "THE PRODUCTS ARE NOT INTENDED, DESIGNED, OR IMPLIED TO DIAGNOSE, CURE, MITIGATE, PREVENT, TREAT OR PROVIDE THERAPY FOR ANY CONDITION." So the disclaimer exists, and it is unambiguous. It also directly contradicts the word Therapy in the product's own store title. Both statements are the vendor's.
Leaf's claims have drawn sustained documented criticism, principally from Dr C. Edward Pitt, a Brisbane general practitioner (MBBS, FRACGP) behind a long blog series, the companion site debunkingdrleaf.com and a 2015 book, Hold That Thought: Reappraising the work of Dr Caroline Leaf. This review does not adjudicate that dispute. It sets out what the app claims, what the cited research contains and what the critics say, with the URLs, and leaves the reader to weigh it. Anyone dealing with anxiety or depression should be doing that weighing with a clinician rather than a review site.
✓ The good
- The structure is genuinely rigorous - 63 days, one cycle per calendar day, three 21-day phases, with the vendor explicitly recommending you not skip ahead, which is more discipline than most wellness apps ask or support
- Writing is a load-bearing step, not a decoration - step three is "write down our reflections to help organize our thinking," so the product is a directed journal with a daily prompt structure rather than an audio library you fall asleep to
- Over 30 mini Neurocycles target named patterns - people-pleasing, overthinking and guilt are called out by name in the store listing, alongside decompression audio guides and parent and child guides
- It publishes its research rather than gesturing at it - its site links a NeuroRegulation paper, a Caspian Journal of Neurological Sciences paper and a Current Psychology scale validation, so the evidence can be read instead of taken on trust
- The financial conflict of interest is declared in the paper itself - the NeuroRegulation article states Leaf "has ownership in Switch on Your Brain and the Neurocycle and financially benefits from royalties for the intellectual property that is subject to evaluation," and reports a double-blind design and a third-party research firm as mitigations
- A real medical disclaimer exists in the terms - it says the product does not treat any condition and that "PEOPLE WITH EXISTING MENTAL HEALTH CONDITIONS SHOULD SPEAK WITH THEIR HEALTH CARE PROVIDERS BEFORE USING THE PRODUCT," which several competitors do not state at all
- Store ratings are strong on iOS - 4.8 from 1,725 ratings, with long user testimonials quoted in the listing itself
✗ Watch out
- There is no free tier at all - the app is a free download with a 3-day trial, after which the entire 63-day program is paywalled, and the vendor states "ALL ORDERS AND SUBSCRIPTIONS ARE NON-REFUNDABLE"
- The headline trial is very small - the NeuroRegulation paper randomised 14 people 7 and 7 and finished with 11, five in the treatment arm and six in control, recruited from patients and staff of one neurology clinic and flyers within a 15-mile radius
- The second study Neurocycle cites is smaller still - the 2023 Caspian Journal paper is a single-subject AB design with four participants total, three trained and one control, all single female students aged 20 to 30 at one university
- The 81% figure is not the published result - drleaf.com presents it as "preliminary results" from a randomised trial, while the peer-reviewed NeuroRegulation paper reports correlations between low beta relative power, homocysteine and anxiety scores, not a percentage reduction
- The store title says Therapy while the terms say the product does not "PROVIDE THERAPY FOR ANY CONDITION" - a reader who only sees the listing gets a materially different product than a reader who opens the legal page
- The Android build is rated 3.6 by roughly 1,450 reviewers against 4.8 from 1,725 on iOS - the same program, two very different verdicts, and English is the only language either store lists
Best for
- Adults who want a fixed 63-day written practice
- Readers of Switch On Your Brain wanting the method guided
- People who journal but drift without daily prompts
- Anyone comfortable evaluating a vendor-funded study
Avoid if
- You are seeking treatment for a diagnosed illness
- You want a free tier to test before paying
- You need Spanish or any non-English language
- Strong causal claims about thought and disease trouble you
What Neurocycle is
Neurocycle is a subscription mobile app that delivers Dr Caroline Leaf's five-step "mind management" method as a 63-day guided course. Each day you work one cycle: Gather Awareness of how you feel mentally and physically, Reflect on it, Write the reflection down, Recheck what it reveals and identify an "antidote," then choose an Active Reach - a single thought or action to rehearse. Screenshots in the Apple listing show a Home screen, a Results view, Mini Neurocycles, Decompression Guides and individual day screens labelled Day 6 and Day 23, which is a fair picture of the shape: a linear day counter with a library alongside it.
Institutionally it is a wellness product from SWITCH ON YOUR BRAIN INTERNATIONAL LLC, in Apple's Health & Fitness category, first released 30 May 2019, at version 3.3.7 as of 22 July 2026, 48.8 MB, English only, iOS 15.1 minimum. Its terms place it in "the health & wellness space" and disclaim medical device status. Faith.tools lists it as a "Christian Mindfulness App"; the app's own storefront copy and marketing site contain no Scripture, with the Christian framing living in Leaf's books, published by Baker Books.
A wellness app that argues from a mechanism
Almost every calm-and-prayer app sells an experience: a voice, a soundscape, a passage, a feeling at the end. Neurocycle sells a causal mechanism. The premise is that thought is the upstream variable - that toxic thinking builds physical structure in the brain, that the structure can be found and dismantled, and that 63 days of directed writing is the tool for doing it. The store listing frames the whole program as "Find the root of the toxic thought and habit that is causing mental health issues," then "Eliminate the root," then "Rebuild a healthy new thought pattern and habit." That is a theory of illness, not a mood offering.
The consequence is that Neurocycle is the only product in this comparison set that can be right or wrong rather than merely liked or disliked. Hallow does not claim a percentage. Abide does not tell you where your anxiety came from. Neurocycle names a mechanism, cites studies, and prints a number, which invites exactly the scrutiny it has received. It also means the app is unusually demanding: 15 to 45 minutes of writing a day for nine weeks is a real commitment, and the vendor asks you to hold one cycle-day per calendar day rather than binge it.
The 63-day program and the five steps
The core product is sequential and unskippable by design. Dr Leaf "recommends that you progress one cycle day for each calendar day in order to get the most out of your Neurocycle program," per the App Store listing, and the program divides into three 21-day phases - the same 21-day unit as her earlier 21-Day Brain Detox material. Each day runs the five steps in order: Gather Awareness, Reflect, Write, Recheck, Active Reach. The writing step is described in Leaf's own material as writing down reflections "to help organize our thinking," and the Recheck step is where you look at what you wrote and derive what she calls an antidote.
Alongside the linear program sit more than 30 "mini Neurocycles," short guided runs of the same five steps aimed at specific habits, with people-pleasing, overthinking and guilt named in the listing, plus decompression audio guides and parent and child guides. That library is the reusable part, the thing left after day 63, and it is also the part the marketing talks about least - homepage and store copy both lead with the 63-day program and the percentage.
The research the app cites, read closely
Neurocycle cites two studies of its own method. The first is Leaf, Turner, Wasserman, Paulson, Kopooshian, Lynch and Leaf, "Psycho-neuro-biological Correlates of Beta Activity," in NeuroRegulation - a pilot study measuring psychometrics, blood-serum homocysteine and quantitative EEG across 63 days. Fourteen participants were randomly assigned, seven to the Neurocycle and seven to a control group receiving "no special attention beyond the standard of care"; after attrition the analysis rests on 11 people, five treatment and six control. Recruitment was from patients and employees of Network Neurology plus flyers posted at the clinic and at colleges within 15 miles. Reported results are correlational - low beta relative power against homocysteine and against HADS anxiety and Leaf Mind Management subscale scores, coefficients cited between .689 and .894 - not a percentage symptom reduction. The paper carries no labelled limitations section and states that "Future work should expand these findings with larger datasets." Leaf is lead author, her affiliation is given as Switch on Your Brain, LLC, and a co-author is at Elite Research, LLC, the firm drleaf.com credits with independent analysis.
The second is Mansoori and Khodabakhshi-Koolaee, "Neurocycle Mind-management Approach: Effect on the Resiliency and Wellbeing of Female University Students," Caspian Journal of Neurological Sciences, volume 9 number 4, pages 210-219, October 2023. It is a single-subject experimental study using an AB model with four participants - three trained, one control - all single female students aged 20 to 30 at Khatam University in 2022. Resilience and wellbeing scores rose above baseline and control to a reliable change index above 1.96, with clinical significance the authors describe as modest and effects persisting at one month. Leaf is not an author. The third cited item validates the Leaf Mind Management Scale in Current Psychology, reported as 20 items in six factors explaining 71.9 percent of variance - a measurement paper, not an efficacy trial. Separately, drleaf.com's clinical trials page describes an 11-participant QEEG assessment at baseline, 21 and 63 days on which "participants significantly improved on performance of all five brain waves," not presented there as peer reviewed.
Where the 81% comes from, and what the critics say
The 81 percent appears on neurocycle.app as "Scientifically demonstrated to show up to 81% improvement in managing symptoms of anxiety and depression." On drleaf.com it is framed as "Preliminary results" that "demonstrated a significant reduction in depression and anxiety, through mind-management, by up to 81%," and Leaf writes there that "we proposed a randomized clinical trial" with an experimental and a control group. The published NeuroRegulation paper from that trial does not headline an 81 percent figure; it reports the correlations described above. So the marketing number is a preliminary in-house result and the peer-reviewed output is a correlational pilot on 11 people. Both are the vendor's own statements and this review reports both rather than reconciling them.
The documented criticism is mostly about the broader body of teaching rather than the app UI. Dr C. Edward Pitt quotes Leaf, citing page 33 of Switch On Your Brain: "Research shows that 75 to 98 percent of mental, physical, and behavioural illness comes from ones thought life." He calls the thought-centred model "pseudo-science," argues the biopsychosocial framework adopted by medicine in the 1980s superseded single-factor explanations, and rejects her position that psychiatric labels "lock people into mental ill-health." He states he raised concerns privately first - "I have respectfully communicated my concerns...privately, to Dr. Leaf herself (via a proxy), and to various pastors" - and that "My purpose here is not to 'bash' Dr Leaf...Rather, I write to hold Dr. Leaf accountable." Susan Brinkmann, writing for the Catholic ministry Women of Grace, gives the same claim as "75 to 95 percent," reports that Leaf holds "a degree in Logopedics and Audiology" and is "not a cognitive neuroscientist by any stretch," relays a neurologist's observation that she "has published only three papers, all of them dating in the 1990s," characterises the approach as "classic New Age thinking," and recommends "giving Dr. Leaf's work a pass." Leaf's own site describes her as a "clinical neuroscientist" with "38 years of research" and "Thousands of brain scans." Readers can compare those descriptions directly.
Pricing
Free download and 3-day trial
Free
The app installs free on iOS and Android and opens a 3-day free trial. There is no ongoing free tier: no free day of the 63-day program, no free mini Neurocycle, nothing published that survives the trial. The Apple listing adds that if you subscribe before the trial ends, "the rest of your free trial period will be forfeited as soon as your purchase is confirmed," so subscribing early costs you the remaining days.
Monthly
$14.99/month
Auto-renewing monthly subscription unlocking the full 63-day program, 30-plus mini audio guides, decompression guides, personalised results and downloadable resources. Twelve months at this rate is $179.88, which is $79.89 more than the annual plan for identical access. The vendor states these prices are for United States customers and that other countries may vary.
3 months
$29.99 per 3 months
The middle tier, and the one that matches the program length most closely - 63 days sits inside a single three-month term with a month to spare. Four of these terms is $119.96 a year against $99.99 for the annual plan, so it only makes sense if you intend to stop after one run. Apple also lists a promotional in-app purchase, "3 Month Promo For NYE" at $19.99, which is not advertised on neurocycle.app.
Full year
$99.99/year
Labelled "Best Value 12 Month" in the Apple in-app purchase list, and it is: 44 percent below the monthly rate over twelve months. Renews automatically until cancelled in your App Store or Google Play account settings at least 24 hours before the period ends. Refunds are excluded by the terms, so the practical protection is the 3-day trial and platform-level cancellation.
Three published tiers, all auto-renewing, all quoted for United States customers: $14.99 monthly, $29.99 for three months, $99.99 for a full year. The same three figures appear on neurocycle.app, on drleaf.com/neurocycle-app, in the Apple listing and on Google Play, which is more consistency than most vendors manage.
The arithmetic favours the year heavily. $14.99 times 12 is $179.88 against $99.99, a saving of $79.89 or 44 percent. The three-month tier at $29.99 times four is $119.96 a year, so it is worth taking only if you plan a single 63-day run and then stop - which, given the program is 63 days long, is a defensible plan and probably the cheapest honest route through the product at $29.99.
Apple's in-app purchase list contains a fourth item the marketing site does not mention: "3 Month Promo For NYE" at $19.99. Promotional pricing is normal; worth knowing it exists before paying $29.99 for the same term.
The trial is three days. That is short against a 63-day program - you will see the onboarding, a day or two of cycles and the mini-guide library, not whether nine weeks of it changes anything. The terms then close the other exit: "ALL ORDERS AND SUBSCRIPTIONS ARE NON-REFUNDABLE." Cancellation is through App Store or Google Play settings at least 24 hours before renewal.
There is no free tier. The app costs nothing to download, and that is the whole of it. Hallow, Abide, Soultime and Glorify all publish an ongoing free layer you can use indefinitely; Neurocycle does not, and the absence is the single biggest practical difference at the point of purchase.
Where Neurocycle falls behind
The evidence base is smaller than the marketing voice. An 11-person correlational pilot and a 4-person single-subject study are legitimate early-stage research and are published where a reader can check them, which is to the vendor's credit. They do not carry "the first ever scientifically-tested brain detox app" or "up to 81% improvement," and no reader should infer from those phrases that a large randomised trial exists, because the cited literature does not contain one.
The store title and the legal page disagree about what the product is. Apple sells it as Stress Therapy: Neurocycle with the subtitle "Get relief from mental anxiety" and a content advisory for intense medical and treatment information; the terms state the product does not "PROVIDE THERAPY FOR ANY CONDITION" and that the company is "NOT A HEALTH CARE OR MEDICAL DEVICE PROVIDER." Same vendor, two descriptions, and the one a buyer reads first is the one that says therapy.
The privacy disclosures do not line up across three surfaces. Google Play's Data Safety section states "No data shared with third parties." The privacy policy on neurocycle.app says "we may disclose your personal information to third parties" including "business partners," describes Google Analytics and advertising "through third party platforms such as Facebook and Google," and reserves the right to disclose information "collected through your use of the Product for research purposes." Apple's privacy label declares Health, Precise Location, Sensitive Info, Contact Info and Identifiers as data linked to you, while the policy describes location only as "zip code, state or country" and never mentions health data. For an app whose input is a daily written record of your worst thoughts, that gap matters more than it would elsewhere.
Ratings and age gates disagree across stores. iOS shows 4.8 from 1,725 ratings; Google Play shows 3.6 from roughly 1,450 reviews on 100K-plus downloads. Apple's lookup returns a 17-plus content rating with a medical-information advisory; Google Play shows "Rated for 3+"; the terms say the product "IS NOT INTENDED FOR CHILDREN UNDER 13" and that under-18s may use it only with parental consent. Three different answers to the same question.
The homepage counts users two ways in the same viewport. It prints "500,000 Users Worldwide" alongside "433,000+ Downloads" - more users than downloads, on one page, with English as the only listed language and Google Play placing installs in the 100K-plus band. Both figures are reported here as printed; neither is adjusted.
Neurocycle vs. Hallow vs. Abide vs. Soultime
These four products all end up on the same phones, and only one of them makes a scientific claim. Hallow is a Catholic prayer app - the largest in the world - at 4.9 from about 366,000 ratings, free tier plus Hallow+ at $8.99 monthly or $69.99 a year. Abide is Scripture-based Christian meditation at 4.9, free tier plus premium around $8.99 monthly, $39.99 a year or $149.99 lifetime. Soultime is a Christian meditation and wellness app at 4.7 from around 5,300 ratings, free tier plus roughly $39.99 a year. Each sells a practice and a feeling. None of them tells you what percentage of your anxiety it will remove.
Neurocycle is the outlier in three ways: it is the most expensive at $99.99 a year against $69.99, $39.99 and $39.99; it is the only one with no ongoing free tier; and it is the only one whose marketing rests on a mechanism and a number. It is also the most demanding - 15 to 45 minutes of writing daily for 63 days, against a ten-minute Hallow session you can skip on a Tuesday. If what you want is a calm ten minutes, three of these four do it cheaper, and one of them does it free.
The split is by what you are after. Want prayer or Scripture-anchored calm: Hallow, Abide or Soultime, and the free tiers mean you can try all three for nothing. Want a structured written protocol with a stated theory of change, and willing to read the underlying papers yourself: Neurocycle is the only one here offering that, and its mini Neurocycles for people-pleasing, overthinking and guilt have no direct equivalent. Want treatment for a diagnosed condition: none of the four is that, and Neurocycle's own terms say so most explicitly.
The bottom line
As a product, Neurocycle is competent and unusually disciplined - a nine-week written protocol with a coherent daily structure and a useful library of short guides, at $99.99 a year with no free tier and no refunds. As a set of claims, it outruns its own citations: an 81 percent headline sits on top of a peer-reviewed pilot that finished with 11 participants and reported correlations rather than percentage reductions, plus a second study with four. Those papers are published and linked, the conflict of interest is declared in the paper, and the criticism from Pitt and Brinkmann is on the public record; a buyer can read all of it in an hour and should. What no one should do is treat this app as care. The vendor agrees: its terms tell people with existing mental health conditions to speak to their health care providers first, and that is the right instruction.
Alternatives to Neurocycle
Frequently asked questions
Is Neurocycle a clinical product or a wellness product?
By its own terms, a wellness product. The terms and conditions state: "COMPANY IS A PROVIDER OF POSITIVE THINKING TRAINING IN THE HEALTH & WELLNESS SPACE. WE ARE NOT A HEALTH CARE OR MEDICAL DEVICE PROVIDER," and that the product "IS NOT INTENDED AS A MEDICAL DEVICE OF ANY TYPE." The marketing reads differently - the Apple listing is titled Stress Therapy: Neurocycle and Apple attaches an advisory for "Frequent/Intense Medical/Treatment Information" - but the legal position is wellness, and the terms are the operative document.
Does it carry a disclaimer about not being medical treatment?
Yes, and it is explicit. The terms say the products are "NOT INTENDED, DESIGNED, OR IMPLIED TO DIAGNOSE, CURE, MITIGATE, PREVENT, TREAT OR PROVIDE THERAPY FOR ANY CONDITION," and that "PEOPLE WITH EXISTING MENTAL HEALTH CONDITIONS SHOULD SPEAK WITH THEIR HEALTH CARE PROVIDERS BEFORE USING THE PRODUCT." That disclaimer is not repeated on the homepage or in the store listing, which is where most buyers decide. If you are dealing with anxiety or depression, follow the disclaimer and talk to a professional.
Where does the "up to 81%" figure come from?
It is presented on neurocycle.app as "Scientifically demonstrated to show up to 81% improvement in managing symptoms of anxiety and depression," and on drleaf.com as "Preliminary results" from a proposed randomised clinical trial showing reduction "by up to 81%." The peer-reviewed paper from that trial - Leaf et al. in NeuroRegulation - does not report an 81 percent reduction; it reports correlations between low beta EEG activity, blood homocysteine and anxiety scores in a final sample of 11 people. The 81 percent is an in-house preliminary figure rather than a published trial result.
What research supports the app, exactly?
Three items, all cited on neurocycle.app. Leaf et al., NeuroRegulation: a pilot randomising 14 participants and analysing 11 (5 treatment, 6 control) over 63 days, Leaf as lead author with a declared financial interest, mitigated per the paper by a double-blind design and a third-party research firm. Mansoori and Khodabakhshi-Koolaee, Caspian Journal of Neurological Sciences 2023: a single-subject AB study of four female students, Leaf not an author. And a Leaf Mind Management Scale validation in Current Psychology, which measures an instrument rather than efficacy. All three are peer reviewed and all three are small.
What is the actual criticism, and who is making it?
The most sustained critic is Dr C. Edward Pitt, a Brisbane GP (MBBS, FRACGP), across cedwardpitt.com, debunkingdrleaf.com and a 2015 book, Hold That Thought. He disputes Leaf's claim - quoted from page 33 of Switch On Your Brain - that "75 to 98 percent of mental, physical, and behavioural illness comes from ones thought life," calls the thought-centred model "pseudo-science," and argues the biopsychosocial model superseded single-factor explanations decades ago. Susan Brinkmann at the Catholic ministry Women of Grace raises credential concerns, reporting Leaf's degree as being "in Logopedics and Audiology," and describes the approach as "classic New Age thinking." Both write as Christians; the objection is scientific rather than doctrinal, and Leaf's side of it is on her own site.
Is there a free version?
No. The download is free and there is a 3-day free trial, after which the 63-day program, the mini Neurocycles and the decompression guides are all behind a subscription. No free daily content is published. The terms also state "ALL ORDERS AND SUBSCRIPTIONS ARE NON-REFUNDABLE," so the trial is the only trial you get. Hallow, Abide, Soultime and Glorify each keep an ongoing free tier.
Is it a Christian app?
Indirectly. Faith.tools lists it as a "Christian Mindfulness App," and Dr Leaf publishes with Baker Books, a Christian publisher - Switch On Your Brain and Help in a Hurry, the latter listed at $26.99. The app's own storefront copy, homepage and science pages contain no Scripture and no devotional framing; they read as secular wellness. If you want Scripture in the session itself, Abide, Hallow and Soultime are built that way and Neurocycle is not.
Sources & further reading
- Neurocycle official site and the 81% claim ↗
- Neurocycle terms and conditions ↗
- Neurocycle privacy policy ↗
- Apple App Store listing, in-app purchases and privacy labels ↗
- Google Play listing and Data Safety disclosures ↗
- Leaf et al., Psycho-neuro-biological Correlates of Beta Activity, NeuroRegulation ↗
- Mansoori and Khodabakhshi-Koolaee, Caspian Journal of Neurological Sciences 2023 ↗
- Dr Leaf: current clinical trials page ↗
- Dr C. Edward Pitt, Dr Caroline Leaf and the Mental Monopoly Myth ↗
- Susan Brinkmann, Women of Grace: Can You Detox Your Brain? ↗
